Friday, May 12
SG01 AIDS/HIV Information on this SIG will be posted on our website in early 2000. 4:15 pm - 6:15 pm - POSTER SESSION I AND OPENING RECEPTION
6:15 pm - 10:15 pm - BOSTON UNIVERSITY SYMPOSIUM New Challenges in the Treatment of
Pediatric HIV Registration Topic Highlights Co-Course Directors Accreditation Grant Support Saturday, May 13 8:00 am - 10:00 am - SUBSPECIALTIES/THEMES (Original Science Abstract Program)
10:15 am - 12:15 pm - SUBSPECIALTIES/THEMES (Original Science Abstract Program)
1:30 pm - 2:30 pm - APS
PRESIDENTIAL PLENARY - HOWLAND AWARD 2:30 pm - 3:00 pm - JOSEPH W.
ST. GEME, JR. LEADERSHIP AWARD Presented on behalf of the American Pediatric Society, American Academy of Pediatrics, American Board of Pediatrics, Ambulatory Pediatric Association, Association of Pediatric Program Directors, Association of Medical School Pediatric Department Chairman and Society for Pediatric Research 3:15 pm - 4:45 pm - STATE OF THE ART PLENARY ¨Pathogenesis of Viral
Respiratory Infections Viruses interact intimately with the host cell environment from the time of initial contact through assembly and release of new infectious virus particles. During infection viruses use preexisting host cell components, modify the intracellular environment, and use mechanisms to avoid host cell immunity in order facilitate their replication and survive to be transmitted to new hosts. The symposium will explore specific aspects of the pathogenesis of four respiratory viral pathogens; the coronaviruses, parainfluenza viruses, influenza virus, and respiratory syncytial virus. The symposium speakers will describe unique features of the replication, cell biology or immune response of each virus and how understanding of molecular mechanisms of pathogenesis provides critical information in efforts to prevent or treat viral respiratory infections. Cellular Pathogenesis of Coronavirus
Infections Receptor Mediated Entry of
Paramyxoviruses Molecular Determinants of Influenza
Virus Virulence Neonatal Immune Response to
Respiratory Syncytial Virus Supported by an educational grant from ICN Pharmaceuticals 5 pm - 7:15 pm - POSTER SESSION II
Sunday, May 14 8:00 am - 10:00 am - SUBSPECIALTIES/THEMES (Original Science Abstract Program)
10:15 am - 12:00 noon - SPR PRESIDENTIAL PLENARY & AWARDS AND E. MEAD JOHNSON AWARD LECTURES Presidential Address: Thomas Hazinski,Vanderbilt University Medical Center Student Awards: Kyle Cowan, Aaron M. Milstone, Christine Siambani House Officer Awards: Douglas D. Fraser, Paul J. Galardy, Matthew A. Saxonhouse Fellow Basic Awards: Christopher E. Belcher, Elif Erkan, Syed Zaidi Fellow Clinical Awards: Michael J. Ackerman, Okan Elidemir, Mika Ramet David Nathan Award: Lisa Wang Young Investigator Award Lecture: E. Mead Johnson Award Lectures: 1:00 pm - 2:15 pm - MARCH OF
DIMES PRIZE IN DEVELOPMENTAL BIOLOGY (Fifth
Annual Lecture) Genetic Control of Programmed
Cell Death in C.elegans 1:15 pm - 2:00 pm - AAP
PRESIDENTIAL PLENARY & JACOBI AWARD 1:30 pm - 4:30 pm - PEDIATRIC
INFECTIOUS DISEASES SOCIETY SYMPOSIUM Management of Common Infections: Experts Opinions with Real World Applications Moderators: New Insights into
Kawasaki Disease Antiviral Agents: Clear
and Present Uses Treatment of Otitis
Media in an Era of Resistance Treatment of Invasive
Infections in an Era of Resistance Management of Common
Dermatologic Infections/Infestations 2:30 pm - 4:30 pm - SUBSPECIALTIES/THEMES (Original Science Abstract Program)
4:45 pm
5:45 pm 4:45 pm - 6:45 pm - POSTER SESSION III
6:30 pm - 10:00 pm
- PIDS RECEPTION, DINNER AND AWARDS For Further
Information Contact: Monday, May 15 8:00 am - 10:00 am - TOPIC SYMPOSIUM ¨Vaccine Dialogue In this interactive dialogue, speakers will engage the audience in discussion of highly important and timely issues related to vaccines. In part one, speakers will discuss latest information regarding the development and performance of conjugate pneumococcal and meningococcal vaccines, as well as the challenges of developing and evaluating novel combination vaccines. In part two, speakers will lead discussions of inherent tensions in implementing vaccine strategies that maximize benefits of scientific discoveries and protect individuals, the public and policy. Mapping the Future of Bacterial and
Combination Vaccines Matching Scientific Progress and
Public Trust Sponsored Jointly with the Pediatric Infectious Diseases Society Supported by educational grants from Merck Vaccine Division and Wyeth-Lederle Vaccines 8:00 am - 10:00 am - SUBSPECIALTIES/THEMES (Original Science Abstract Programs)
8:00 am - 10:00 am - RICHARD E.
ROWE AWARD 8:30 am - 12:30 pm - APA
PRESIDENTIAL PLENARY & ARMSTRONG LECTURE 10:15 am - 11:45 am - STATE OF THE ART PLENARY ¨Gene-Based Understanding of
X-linked Primary Immunodeficiency Disorders This session can bring all pediatricians up-to-date on the astounding information explosion in this area and point out how correction may be possible for most of these diseases for which the molecular basis is known. It will also emphasize the key role pediatricians have in identifying these patients prior to the development of serious infections. X-linked Severe Combined
Immunodeficiency Wiskott-Aldrich Syndrome X-linked Lymphoproliferative Disease Supported by the National Institute of Child Health & Human Development ¨Pediatrics in the New
Millennium: Compelling Issues in Public Policy - 7th
Annual Public Policy Plenary This is the 7th annual Public Policy Plenary Symposium organized and sponsored by the Public Policy Council, which coordinates public policy activities for the APS, SPR and AMSPDC, in collaboration with the APA Public Affairs Committee. The year 2000 program will look forward to the new millennium and broadly examine the outlook for childrens health in three vital areas: (1) access to health care (2) testing and access of children to drugs and devices and (3) the pipeline for pediatric physician-investigators and the future of academic pediatrics. We have set aside significant time at the conclusion of the speakers formal presentations to permit interactive dialogue between members of the panel and the audience. Childrens Access to Health
Care - Removing the Financial Barrier Increasing Pediatric Access to
Medical Therapies The Pipeline of Physician-Scientist
in Pediatrics Supported in part by an educational grant from the Columbus Children's Hospital, Columbus, Ohio 1:00 pm - 4:00 pm - TOPIC SYMPOSIUM ¨Infections in the NICU: State
of the Art, 2000 This multidisciplinary session will provide participants with a state-of-the-art update on the epidemiology, microbiology, clinical presentations, diagnostic and management issues related to infections in the NICU. The three lecture-style presentations will include an update of the non-antibiotic treatment issues in the septic newborn. Participants will review an updated evaluation of the current evidence for efficacy on the use of recombinant hematopoietic growth factors, intravenous immune globulin, and granulocyte transfusions in the NICU. The second lecture will focus on the current state of the art related to nosocomial infections in the NICU. The final lecture will focus on fungal infections in the NICU and will provide information on the clinical presentation, diagnostic workup, and treatment in newborns. There will be question and answer opportunities after each lecture with a panel discussion at the end of the workshop. The goal of the session will be to provide the participants with the latest analysis of non-antibiotic or anti-fungal therapy in newborns and an update on nosocomial and fungal infections in the NICU. The Use of Recombinant Hematopoietic
Growth Factors, Intravenous Immune Globulin, and
Granulocyte Transfusions in the NICU: Weighing the
Evidence of Efficacy. Nosocomial Infections in the NICU:
Causes and Cures Fungal Infection in the Newborn:
Suspect It, Detect It, Correct It. 1:00 pm - 3:00 pm - SUBSPECIALTIES/THEMES (Original Science Abstract Program)
3:15 pm - 4:45 pm - STATE OF THE ART PLENARY ¨Achieving Good Health For the
Worlds Children The health of the worlds children is important to the future of the world. This plenary session will explore basic principles of world health for children and suggest ways in which pediatricians all over the world can work together to achieve better and brighter futures for all of our children. The concept of a world community of pediatricians bearing a collective responsibility for the health of children will be explored. Existing standards will be discussed, including training and professional standards of our pediatric profession around the world, concepts of medical ethics which govern our behavior as physicians, and concepts of childrens rights which exist in international law and define world standards for the treatment of children. Adopting a broad definition of child health which includes physical, mental, and social health, the disease burdens of children around the world now and in the 21st century will be presented, along with some concepts of how these burdens might be lessened. Finally, the roles that pediatricians can play in humanitarian response to emergencies and disasters will be presented. Time will be allowed for discussion from members of the audience, who are encouraged to think about these issues in advance and be prepared to add their voices to the discussion. World Community: Children and
Pediatricians, A Collective Responsibility World Standards: Professional
Standards, Medical Ethics, Childrens Rights World Health: Disease Burdens for
Children Now and in the 21st Century World Disasters: the Special Needs
of Children Supported by an educational grant from Johnson & Johnson Pediatrics Institute 5:00 pm - 7:00 pm - POSTER SESSION IV
Tuesday, May 16 8:00 am - 10:00 am - SUBSPECIALTIES/THEMES (Original Science Abstract Program)
WS47 Group A Strep: A Pathogen
For Every Millennium M. T. Brady, The Ohio State University, Childrens Hospital, Columbus; M. A. Gerber, National Institute of Health, Bethesda; E. L. Kaplan, University of Minnesota Medical School, Department of Pediatrics, Minneapolis; S. T. Shulman, Northwestern University, Childrens Memorial Hospital, Division of Infectious Diseases, Chicago; D. L. Stevens, VA Medical Center, Boise; R. Tanz, Childrens Memorial Hospital, Chicago 10:15 am - 12:15 pm - POSTER SESSION V
12:15 pm - 2:15 pm - HOT TOPIC ¨Whats New in the Red
Book? This session will highlight substantial changes and additions in the diagnosis, treatment and prevention of infectious diseases that have been made in the Year 2000 Red Book. Some of the topics that will be discussed include meningococcal vaccine, ibuprofen and risk of systemic group A strep infection, herpes simplex disseminated and CNS disease, hepatitis A vaccine, lyme disease, mercury in vaccines, polio, rotavirus and pneumococcal disease. Jon S. Abramson, Wake Forest University
School of Medicine, Winston-Salem Supported by an educational grant from Merck Vaccine Division PAS/AAP Joint
Meeting Index Page Last Modified: April 12, 2000 |